Fever and infections in pregnancy and risk of attention deficit/hyperactivity disorder in the offspring

2015 ◽  
Vol 57 (4) ◽  
pp. 540-548 ◽  
Author(s):  
Julie Werenberg Dreier ◽  
Anne‐Marie Nybo Andersen ◽  
Allan Hvolby ◽  
Ester Garne ◽  
Per Kragh Andersen ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
In Pregnancy

Maternal Lifestyle Factors in Pregnancy Risk of Attention Deficit Hyperactivity Disorder and Associated Behaviors: Review of the Current Evidence

2003 ◽  
Vol 160 (6) ◽  
pp. 1028-1040 ◽  
Author(s):  
Karen Markussen Linnet ◽  
Søren Dalsgaard ◽  
Carsten Obel ◽  
Kirsten Wisborg ◽  
Tine Brink Henriksen ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Lifestyle Factors ◽  
Current Evidence ◽  
Pregnancy Risk ◽  
Hyperactivity Disorder ◽  
In Pregnancy

Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood

Epidemiology ◽  
2015 ◽  
Vol 26 (4) ◽  
pp. 458-465 ◽  
Author(s):  
Eva Morales ◽  
Jordi Julvez ◽  
Maties Torrent ◽  
Ferran Ballester ◽  
Clara L. Rodríguez-Bernal ◽  
...  
Keyword(s):  
Vitamin D ◽  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
In Pregnancy

The effects of drugs used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) on pregnancy outcome and breast feeding: a critical review

2020 ◽  
Vol 18 ◽  
Author(s):  
Asher Ornoy ◽  
Gideon Koren
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Breast Feeding ◽  
Attention Deficit ◽  
Clinical Symptoms ◽  
School Age Children ◽  
Published Data ◽  
Hyperactivity Disorder ◽  
Child Bearing ◽  
Norepinephrine Reuptake Inhibitor ◽  
In Pregnancy

: Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral condition found in 5-10% of school age children and in 2-5% of adults. Stimulants, affecting the dopaminergic, noradrenergic and/or serotonergic systems are commonly used for treatment in children and adults, including women of child bearing age. The data on the effects of stimulants (methylphenidate and amphetamines) in pregnancy are generally reassuring but methylphenidate might slightly increase the rate of cardiac malformations and of spontaneous abortions, while amphetamines might slightly increase the risk for premature birth, low birth weight and other pregnancy complications. Bupropion, a dopamine and norepinephrine reuptake inhibitor, when used as an antidepressant appears to be safe in pregnancy. The data on the use of atomoxetine, guanfacine and clonidine in pregnancy are scarce. Importantly, there are practically no data on the long-term neurodevelopmental effects of most of these drugs. The published data on the development of children born to methamphetamine- abusing women may be misleading since these women generally use other drugs including alcohol and the home environment where the child is raised may not be optimal. The treating physician should judge the need of treatment during pregnancy in relation to the severity of the clinical symptoms. If needed, methylphenidate is preferred over amphetamines because breast feeding is possible. If one uses non-stimulant medications bupropion seems to be the preferred drug.

scholarly journals Gilles de la Tourette syndrome in pregnancy: a retrospective series

2009 ◽  
Vol 2 (3) ◽  
pp. 128-129 ◽  
Author(s):  
J S Stern ◽  
M Orth ◽  
M M Robertson
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Case Report ◽  
Adverse Effects ◽  
Tourette Syndrome ◽  
Attention Deficit ◽  
Postal Questionnaire ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Hyperactivity Disorder ◽  
In Pregnancy

Tourette syndrome is a neuropsychiatric syndrome characterized by motor and vocal tics with further co-morbidities, e.g. obsessive–compulsive disorder and attention deficit hyperactivity disorder. There is only a single prior case report in pregnancy in addition to a postal questionnaire study including 10 pregnancies. In a series of 11 pregnancies in patients assessed by the authors, there were no adverse effects on the pregnancy, although some obstetricians were unduly concerned. There was no consistent effect on the severity of the tics, although in some women there seemed to be a significant improvement during pregnancy.

Sign in / Sign up

Export Citation Format

Share Document